| Dr Frank A Baffoni, MD | |
|
300 Tollgate Rd, Ste 207, Warwick, RI 02886 | |
| (401) 738-3275 | |
| (401) 737-9134 |
| Full Name | Dr Frank A Baffoni |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 300 Tollgate Rd, Warwick, Rhode Island |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093828576 | NPI | - | NPPES |
| 9020175 | Medicaid | RI | |
| 004715 | Other | RI | BLUE INF |
| 0402446 | Other | RI | UH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD7710 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Frank A Baffoni, MD 300 Tollgate Rd, Ste 207, Warwick, RI 02886 Ph: (401) 738-3275 | Dr Frank A Baffoni, MD 300 Tollgate Rd, Ste 207, Warwick, RI 02886 Ph: (401) 738-3275 |
News Archive
SafeStitch Medical, Inc. announced today that it has received CE Mark authorization to commercialize its AMID StaplerTM in the European Economic Community. The new stapler is to be used for fixation of mesh in the repair of hernia defects and also for the approximation of tissues, including skin. The AMID Stapler™ is the first surgical stapler designed specifically for use in inguinal hernia repairs using the Lichtenstein method, in which mesh is implanted for reinforcement. SafeStitch announced in November 2009 that it had received 510(k) clearance from the Food and Drug Administration for sale of the AMID StaplerTM in the U.S. market.
It has been more than 50 years since the U.S. Food and Drug Administration (FDA) last approved a new medicine specifically for lupus – when Dwight D. Eisenhower was president. Existing treatments have been "borrowed" from other disorders and the risk/benefit ratio of these treatments is far from optimal. However, hope is on the horizon.
Soft drink consumption has increased in both the USA and the UK over the years and this has often been blamed for a rise in childhood body mass index (BMI).
Aiming to help researchers get a better handle on how - and if - anticancer agents are triggering cell death, investigators at the University of Twente in The Netherlands have developed a quantum dot nanodevice that can detect and image apoptosis, also known as programmed cell death.
Results from the phase III REPLACE trial of recombinant human parathyroid hormone (rhPTH) indicate the treatment can successfully combat the underlying deficit in hypoparathyroidism.
› Verified 5 days ago
Dr. Sterling Leaf Malish, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7000 | |
Dr. John David Lowney, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1030 Warwick Ave, Warwick, RI 02888 Phone: 401-467-6257 Fax: 401-785-1191 | |
Dr. Christian Rene Herard, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 Tollgate Road, Suite 302, Warwick, RI 02886 Phone: 401-738-4014 Fax: 401-738-4090 | |
John A Gelzhiser, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7000 Fax: 401-736-4265 | |
Dr. Michael Seidler, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 125 Metro Center Blvd Ste 2000, Warwick, RI 02886 Phone: 401-921-9202 Fax: 401-921-9212 | |
Murli K Raman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 455 Tollgate Rd, Brigham & Women's Cardiovascular Associates At Cne, Warwick, RI 02886 Phone: 401-681-4996 Fax: 401-921-6569 | |
Dr. Jennifer F Jarbeau, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 Bald Hill Rd Ste 524, Warwick, RI 02886 Phone: 401-737-7313 Fax: 401-737-4207 |